2025
SJR Q1
JCR Q2 · 4,5
132 matched articles
SCIE
Journal detail
Clinical and Experimental Medicine
- Publisher
- Springer Science and Business Media Deutschland GmbH
- Country
- Germany · Western Europe
- Type
- journal
- ISSN
-
1591889015919528
Integrated evaluation
Scopus side is Scimago SJR; WoS side is Master Journal List + JCR/JIF. Sources are matched on ISSN. WoS / JCR metrics are available for 1997 and later years only.
WoS / JCR data covers 1997 onward.
Scopus
Scopus · Scimago
- SJR 1,176
- Quartile Q1
- H-Index 64
- Cites/doc 4,49
- Docs (3y) 756
- Cites (3y) 3.429
Clarivate
Web of Science · JCR · 2025
- JCR Q Q2
- JIF 4,5
- 5Y JIF 4,4
- JCI 0,73
WoS indexes
- SCIE
Subject classification
Categories (SJR)
WoS categories
Yearly quartile comparison
Scimago (SJR) for all years; Clarivate (JCR / JIF / JCI) from 1997 onward. Latest year stays open; older years start collapsed.
WoS / JCR data covers 1997 onward.
| Year | SJR Q | JCR Q (1997+) | SJR | JIF (1997+) | 5Y JIF (1997+) | JCI (1997+) | JCI Q (1997+) | H-Index |
|---|---|---|---|---|---|---|---|---|
| 2025 | Q1 | Q2 | 1,176 | 4,5 | 4,4 | 0,73 | Q2 | 64 |
| 2024 | Q1 | Q2 | 1 | 3,5 | 3,6 | 0,7 | Q2 | 59 |
| 2023 | Q1 | Q2 | 1,038 | 3,2 | 3,4 | 0,68 | Q2 | 59 |
| 2022 | Q1 | Q2 | 0,984 | 4,6 | 4 | 0,84 | Q2 | 59 |
| 2021 | Q1 | Q2 | 0,902 | 5,1 | 4 | 0,87 | Q2 | 59 |
| 2020 | Q1 | Q3 | 1,098 | 4 | 3,5 | 0,95 | Q2 | 59 |
| 2019 | Q2 | Q3 | 0,73 | 2,6 | 2,6 | 0,93 | Q2 | 59 |
| 2018 | — | Q3 | — | 2,6 | 2,4 | 1,03 | Q2 | — |
| 2017 | Q2 | Q2 | 0,848 | 2,8 | 2,5 | 0,97 | Q2 | 59 |
| 2016 | Q2 | Q2 | 0,881 | 2,9 | 2,7 | — | — | 59 |
| 2015 | Q1 | Q2 | 0,979 | 2,9 | 2,4 | — | — | 59 |
| 2014 | Q2 | Q2 | 0,849 | 3 | 2,2 | — | — | 59 |
| 2013 | Q1 | Q2 | 0,864 | 2,8 | 2,1 | — | — | 59 |
| 2012 | Q2 | Q2 | 0,674 | 2,4 | 1,9 | — | — | 59 |
| 2011 | Q2 | Q3 | 0,604 | 2 | 1,8 | — | — | 59 |
| 2010 | Q2 | Q3 | 0,51 | 1,6 | 1,7 | — | — | 59 |
| 2009 | — | Q3 | — | 1,6 | 1,7 | — | — | — |
| 2008 | — | Q3 | — | 2 | 1,9 | — | — | — |
| 2007 | — | Q3 | — | 1,5 | 1,6 | — | — | — |
| 2006 | — | Q3 | — | 1,6 | — | — | — | — |
| 2005 | — | Q3 | — | 1,2 | — | — | — | — |
| 2004 | — | Q3 | — | 0,9 | — | — | — | — |
| 2003 | — | Q3 | — | 0,9 | — | — | — | — |
| 2002 | — | Q4 | — | 0,5 | — | — | — | — |
JCR category quartile history
JCR / JCI quartile by year and category. 1997 and later.
WoS / JCR data covers 1997 onward.
| Year | Category | Edition | JCR Q (1997+) | JCI Q (1997+) | Rank |
|---|---|---|---|---|---|
| 2025 | MEDICINE, RESEARCH & EXPERIMENTAL | SCIE | Q2 | Q2 | 59/191 |
| 2024 | MEDICINE, RESEARCH & EXPERIMENTAL | SCIE | Q2 | Q2 | 68/195 |
| 2023 | MEDICINE, RESEARCH & EXPERIMENTAL | SCIE | Q2 | Q2 | 81/189 |
| 2022 | MEDICINE, RESEARCH & EXPERIMENTAL | SCIE | Q2 | Q2 | 58/136 |
| 2021 | MEDICINE, RESEARCH & EXPERIMENTAL | SCIE | Q2 | Q2 | 57/139 |
| 2020 | MEDICINE, RESEARCH & EXPERIMENTAL | SCIE | Q3 | Q2 | 72/140 |
| 2019 | MEDICINE, RESEARCH & EXPERIMENTAL | SCIE | Q3 | Q2 | 78/139 |
| 2018 | MEDICINE, RESEARCH & EXPERIMENTAL | SCIE | Q3 | Q2 | 72/136 |
| 2017 | MEDICINE, RESEARCH & EXPERIMENTAL | SCIE | Q2 | Q2 | 64/133 |
| 2016 | MEDICINE, RESEARCH & EXPERIMENTAL | SCIE | Q2 | — | 46/128 |
| 2015 | MEDICINE, RESEARCH & EXPERIMENTAL | SCIE | Q2 | — | 49/124 |
| 2014 | MEDICINE, RESEARCH & EXPERIMENTAL | SCIE | Q2 | — | 45/123 |
| 2013 | MEDICINE, RESEARCH & EXPERIMENTAL | SCIE | Q2 | — | 46/124 |
| 2012 | MEDICINE, RESEARCH & EXPERIMENTAL | SCIE | Q2 | — | 58/121 |
| 2011 | MEDICINE, RESEARCH & EXPERIMENTAL | SCIE | Q3 | — | 61/112 |
| 2010 | MEDICINE, RESEARCH & EXPERIMENTAL | SCIE | Q3 | — | 65/106 |
| 2009 | MEDICINE, RESEARCH & EXPERIMENTAL | SCIE | Q3 | — | 59/93 |
| 2008 | MEDICINE, RESEARCH & EXPERIMENTAL | SCIE | Q3 | — | 47/83 |
| 2007 | MEDICINE, RESEARCH & EXPERIMENTAL | SCIE | Q3 | — | 50/81 |
| 2006 | MEDICINE, RESEARCH & EXPERIMENTAL | SCIE | Q3 | — | 46/76 |
| 2005 | MEDICINE, RESEARCH & EXPERIMENTAL | SCIE | Q3 | — | 50/72 |
| 2004 | MEDICINE, RESEARCH & EXPERIMENTAL | SCIE | Q3 | — | 51/71 |
| 2003 | MEDICINE, RESEARCH & EXPERIMENTAL | SCIE | Q3 | — | 51/72 |
| 2002 | MEDICINE, RESEARCH & EXPERIMENTAL | SCIE | Q4 | — | 66/74 |